Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT07558655
Active, not recruiting Observational

The Glean Registry

NCT07558655 · tracked via the Priya Life Science USA tracker
Sponsor
Bright Uro
Phase
Observational
Started
2026-04-16
Last updated
2026-04-30

Condition(s) studied

UrologyUrodynamics

Investigational drug(s) / intervention(s)

Glean Urodynamics System

Glean Urodynamics System: Glean Urodynamics System including pressure and flow measurements, and software apps.

Study summary

A registry designed to collect real-world data (RWD) on the Glean Urodynamics System via a retrospective medical chart review.

Eligibility

Sex
ALL
Min age
22 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male or female adult age 22 years or older * Underwent UDS testing using the Glean Urodynamics System * Glean UDS has been interpreted by the clinician Exclusion Criteria: \- Did not have both pressure and flow urodynamic parameters recorded using Glean.

Primary outcome measure(s)

  • Collection of Demographic and Procedural Information on Patients Who Underwent Glean Urodynamics — Perioperative/Periprocedural

Trial sites (1)

FacilityCityRegionStatus
Palmetto Adult and Children's Urology North Charleston South Carolina

More Bright Uro trials in the USA

Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults Recruiting
Ambulatory Long Length URodynamics Evaluation Recruiting

Other trials for the same condition

A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth Recruiting
Ambulatory Long Length URodynamics Evaluation Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07558655 on ClinicalTrials.gov ↗ ← All trials in the USA